pipette
ENEnglish

A Data-Driven Pediatric Type 1 Diabetes Population Health Model Within Specialty Value-Based Care

D. R. Pahud, L. A. Harris, B. Lockee, K. E. Noland, J. Redel, D. R. Tilden, K. Diederich, R. Moran, M. A. Clements, J. C. Espinoza

PreprintUso en el mundo real

En palabras de los autores

Objective: Pediatric specialty value-based care (VBC) for chronic conditions remains under-described. We describe the design and early performance of a data-driven population health model for pediatric type 1 diabetes within a specialty VBC program. Research Design and Methods: Descriptive evaluation at a single academic pediatric medical center and clinically integrated network, 2021-2025, with formal VBC operation beginning in 2024. Participants were children and adolescents with type 1 diabetes attributed through commercial and Medicaid value-based agreements (n=786 in 2025). The program paired infrastructure funding with performance-dependent payments tied to clinical quality and utilization measures, supported by remote monitoring and care management. Measures: percentage receiving the chronic care intervention, population median HbA1c, percentage with HbA1c >9% (75 mmol/mol), percentage with [≥]1 diabetic ketoacidosis (DKA) admission, and inpatient and emergency department (ED) visit rates per 1,000/month. Results: From 2021 to 2025, median HbA1c decreased from 8.6% (70 mmol/mol) to 7.9% (63 mmol/mol), HbA1c >9% (75 mmol/mol) decreased from 41.1% to 27.6%, and [≥]1 DKA admission decreased from 9.1% to 5.6%. Inpatient admissions per 1,000/month decreased from 11.2 to 7.4 and ED visits from 10.0 to 7.6. The program met 3 of 6 targets in 2024 and all 6 in 2025. Conclusions: Pairing infrastructure funding with performance-dependent payments was feasible and associated with sustained improvements in glycemic control and reduced acute care utilization. Further multi-site evaluation is needed to determine impact, generalizability, and sustainability.

Resultado principalLimitación que admiten los autores

Apareció: sábado, 24 de octubre. medRxiv. Preprint, todavía sin revisión por pares.

DOI: 10.64898/2026.10.21.26365944